Open AccessSurvival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Author(s) -
R.M. Smeenk,
Victor J. Verwaal,
Ninja Antonini,
F.A.N. Zoetmulder
Publication year - 2007
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/01.sla.0000231705.40081.1a
Subject(s) - medicine , pseudomyxoma peritonei , hyperthermic intraperitoneal chemotherapy , surgery , confidence interval , pathological , chemotherapy , survival analysis , gastroenterology , survival rate , cytoreductive surgery , cancer , appendix , ovarian cancer , paleontology , biology
To evaluate the survival of patients with pseudomyxoma peritonei (PMP) treated by cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC), and to identify factors with prognostic value.